Quick Search

PHDS HEALTHCARE RESEARCH Co., Ltd. (CRO) is a CRO company serving the world, a national high-tech enterprise, and one of the leading contract research institutions (Contract Research Organization) in the industry.

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News

Jelly Belly jelly beans enter the Chinese market


Release time:

2006-01-10

PHDS has applied to the Chinese Ministry of Health to expand the usage of color additives for a series of 50 flavors of jelly beans from the American company JEIIY BELLY, and has received approval.

Jelly Belly jelly beans enter the Chinese market

PHDS applied to the Chinese Ministry of Health to expand the usage of color additives for the 50 flavors of Jelly Belly candies produced by the American company JEIIY BELLY, and received approval.

In the announcement No. 1 of 2006 published by the Chinese Ministry of Health on January 26, 2006, the five color additives contained in JEIIY BELLY jelly beans were all approved for expanded usage. This allowed the JEIIY BELLY jelly beans, which have been sold in Europe and the United States for over a hundred years, to finally enter the Chinese market after a five-month application process.

Jelly Belly is a famous candy manufacturer in the United States, which has been producing various delicious candies since 1869. After more than a hundred years of continuous improvement and development, Jelly Belly candies are now known as some of the most delicious and popular candies in the world. Last year, PHDS handled the application for the quantity and types of food additives for Jelly Belly's 50 flavors of jelly beans. These delicious candies officially entered the Chinese market in early 2006 after completing the application for multiple food additive additions, winning the love of Chinese consumers.

Keyword:

Relevant regulations and policies


Key points and judgment principles for the quality management of non-clinical research of drugs

In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."

2024-11-22

Technical requirements for the latest declaration data electronic disc

In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.

2024-11-22

PHDS was elected as: Vice President unit of the China Food and Drug Enterprise Quality Safety Promotion Association

In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.

2024-11-22

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

2024-11-22